Stryker Corp
NYSE:SYK
Intrinsic Value
Stryker Corp. engages in the provision of medical technology products and services. [ Read More ]
The intrinsic value of one SYK stock under the Base Case scenario is 265.29 USD. Compared to the current market price of 336.22 USD, Stryker Corp is Overvalued by 21%.
Valuation Backtest
Stryker Corp
Run backtest to discover the historical profit from buying and selling SYK stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Stryker Corp
Current Assets | 12.5B |
Cash & Short-Term Investments | 3B |
Receivables | 3.8B |
Other Current Assets | 5.7B |
Non-Current Assets | 27.4B |
PP&E | 3.7B |
Intangibles | 19.8B |
Other Non-Current Assets | 3.8B |
Current Liabilities | 7.9B |
Accounts Payable | 1.5B |
Accrued Liabilities | 3.6B |
Other Current Liabilities | 2.8B |
Non-Current Liabilities | 13.4B |
Long-Term Debt | 10.9B |
Other Non-Current Liabilities | 2.5B |
Earnings Waterfall
Stryker Corp
Revenue
|
20.5B
USD
|
Cost of Revenue
|
-7.4B
USD
|
Gross Profit
|
13.1B
USD
|
Operating Expenses
|
-8.7B
USD
|
Operating Income
|
4.4B
USD
|
Other Expenses
|
-1.2B
USD
|
Net Income
|
3.2B
USD
|
Free Cash Flow Analysis
Stryker Corp
SYK Profitability Score
Profitability Due Diligence
Stryker Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Stryker Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
SYK Solvency Score
Solvency Due Diligence
Stryker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Stryker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SYK Price Targets Summary
Stryker Corp
According to Wall Street analysts, the average 1-year price target for SYK is 379.48 USD with a low forecast of 342.39 USD and a high forecast of 426.3 USD.
Ownership
SYK Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SYK Price
Stryker Corp
Average Annual Return | 8.64% |
Standard Deviation of Annual Returns | 10.57% |
Max Drawdown | -44% |
Market Capitalization | 126.9B USD |
Shares Outstanding | 383 900 000 |
Percentage of Shares Shorted | 1.17% |
SYK News
Last Important Events
Stryker Corp
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Stryker Corp
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Stryker Corp. engages in the provision of medical technology products and services. The company is headquartered in Portage, Michigan and currently employs 46,000 full-time employees. The firm offers products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine that help improve patient and hospital outcomes. Its products are sold in approximately 75 countries through Company-owned subsidiaries and branches, as well as, third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a range of medical specialties. Its business segments include MedSurg and Neurotechnology and Orthopaedics and Spine. Its subsidiaries include Alcott Indemnity Company, Arrinex, Inc., Berchtold Corporation, and BioMimetic Therapeutics, LLC.
Contact
IPO
Employees
Officers
The intrinsic value of one SYK stock under the Base Case scenario is 265.29 USD.
Compared to the current market price of 336.22 USD, Stryker Corp is Overvalued by 21%.